Bridgesheet

Financial modelling7 min read

Accretion Dilution: How to Read a Merger Model

An acquisition is accretive if it increases the buyer's earnings per share, and dilutive if it reduces it. The result depends mainly on two things: the price paid and how the deal is financed.

Aerial view of two rivers of different colours flowing together
Photo: Carsten Steger · CC BY-SA · Wikimedia

Accretion dilution: what are we talking about

When a listed company buys another, the first question from the board and the analysts is almost always the same: is the deal accretive or dilutive? Accretion dilution analysis compares the earnings per share (EPS, net income divided by the number of shares) of the acquirer on its own with that of the combined group after the deal, known as pro forma EPS. If it rises, the deal is accretive; if it falls, it is dilutive.

This test is not a valuation. It does not say whether the price is fair, only what the deal does to earnings per share over the following one to three years. But it is the figure the market looks at on the day of the announcement, and an acquirer that presents heavy dilution without an explanation often sees its share price fall. Knowing how to read an accretion dilution model means knowing what moves this number, and what it hides.

Calculating pro forma EPS, step by step

The calculation takes five steps, for a given year (often the first full year after completion):

  1. The price of the target's shares. The unaffected share price (before the announcement), multiplied by the number of shares (including options), plus the control premium (the extra paid to gain a majority, often 20% to 40%).
  2. The uses of funds. The price of the shares, plus transaction fees (banks, advisers, lawyers) and, where relevant, the refinancing of the target's debt.
  3. The sources of funds. How the buyer pays: new shares issued at its own share price, new debt, or cash already on the balance sheet.
  4. Combined net income. The acquirer's net income, plus the target's, minus the after-tax interest on the new debt, minus the interest lost on the cash used, plus after-tax synergies, minus the amortisation of the intangible assets revalued in the purchase price allocation.
  5. Pro forma EPS. Combined net income divided by the acquirer's number of shares plus the new shares. It is compared with the acquirer's standalone EPS for the same year.

Transaction fees are paid once; they are financed in the sources of funds, but removed from recurring earnings so as not to distort the comparison.

Worked example: the same purchase financed three ways

Vectral, a fictional listed industrial group, wants to buy Orséa, a smaller company that is also listed. The year 1 figures:

Vectral (acquirer) Orséa (target)
Share price €50 €20
Number of shares 20 million 10 million
Market capitalisation €1,000m €200m
Net income €80m €20m
EPS €4.00 €2.00
P/E (price ÷ EPS) 12.5x 10.0x

Vectral offers a 30% premium: €26 per share, or €260m for the shares, which is 13 times Orséa's net income. With 2% in fees (€5.2m), it needs to raise €265.2m. The tax rate is 25% and the new debt costs 5% before tax, or 3.75% after tax. Synergies and growth are set aside to isolate the effect of the financing.

100% stock 100% debt 50% stock, 50% debt
New shares issued at €50 5.30 million 0 2.65 million
After-tax interest 0 €9.9m €5.0m
Combined net income €100.0m €90.1m €95.0m
Number of shares 25.30 million 20.00 million 22.65 million
Pro forma EPS €3.95 €4.50 €4.20
Accretion or dilution -1.2% +12.6% +4.9%

Same target, same price, three different answers. Paid for in stock, the deal dilutes Vectral's EPS; paid for in debt, it is accretive by more than 12%.

The quick rule: compare the cost of each source of funding

You can guess the sign of the result without rebuilding the whole table. Simply compare what the target earns at the price paid with what each euro of financing costs, after tax.

  • The target's yield at the price paid: its net income divided by total uses of funds. Here 20 ÷ 265.2 = 7.5%.
  • The cost of stock: the inverse of the acquirer's P/E, known as the earnings yield. Here 1 ÷ 12.5 = 8.0%. Every euro raised in stock "costs" existing shareholders 8 cents of earnings.
  • The cost of debt: its after-tax rate, here 3.75%.
  • The cost of cash: the interest it will no longer earn, after tax. At 3% before tax, 2.25%.
Funding After-tax cost Target yield Effect on EPS
Stock 8.0% 7.5% Dilutive
Debt 3.75% 7.5% Accretive
Cash 2.25% 7.5% Accretive

If the funding costs less than the target earns, the deal is accretive, and vice versa. For a stock deal, the rule comes down to comparing P/E ratios: an acquirer that pays more for the target than its own P/E (here 13.3 times, fees included, against 12.5) dilutes its earnings per share. For the all-stock deal to be neutral, Vectral should spend no more than €250m in total, a premium of about 22.5% instead of 30%.

The P/E ratio and how it is used across a sample of listed companies are covered in our article on trading comparables.

Breakeven synergies: the savings that erase dilution

Synergies are the cost savings or extra sales that the combination is expected to produce: joint purchasing, merged sites, one company's products sold to the other's customers. In a merger model, you calculate the breakeven synergies, the amount needed for the deal to stop being dilutive. To value them and decide how much of them to pay the seller, see our article on acquisition synergies.

In the all-stock scenario, Vectral needs combined net income of €4.00 × 25.30 million shares = €101.2m, which is €1.2m more. After 25% tax, that represents a little over €1.6m of pre-tax synergies. If management announces €10m, the safety margin is wide; if it targets none in particular, dilution is the most likely scenario.

Two caveats. Cost synergies are more credible than revenue synergies, and the market rarely gives full credit for them. And they arrive gradually: they are often phased in over two or three years, with restructuring costs in the first year, which can make year 1 dilutive even though year 3 is accretive.

Accretion does not mean value creation

Vectral's all-debt scenario lifts EPS by 12.6%. That does not make it better for the shareholder.

  • Risk goes up. €265m of new debt increases the group's leverage. Shareholders then demand a higher return, and the group's P/E may fall. If the market moves from 12.5 to 11 times earnings, EPS of €4.50 gives a share price of €49.50, below the starting €50.
  • Price matters more than financing. A deal paid for at too high a price destroys value, even if it is accretive thanks to cheap debt. To judge the price, compare what the target is worth, with synergies, against what you pay, using a DCF and precedent transactions. The cost of capital to use is explained in our article on calculating WACC.
  • EPS ignores the target's debt. If Orséa had €100m of net debt, refinanced by Vectral, the price paid for the business would be well above the €260m for the shares. The bridge from one to the other is described in our article on enterprise value vs equity value.

Common mistakes in a merger model

  • Using a share price affected by rumours. The premium is calculated on the price before the leaks; otherwise it is understated.
  • Forgetting potential shares. The target's options, free shares and convertible bonds are part of the price, and the acquirer's are part of the share count.
  • Leaving fees in recurring earnings. They weigh on the year of the deal, not on the following years.
  • Omitting the purchase price allocation. Part of the gap between the price and the target's equity is assigned to intangible assets (brands, customer relationships) that are amortised every year, which reduces pro forma earnings. The rule on the remaining goodwill depends on the accounting framework.
  • Looking at only one year. A deal that is dilutive in year 1 can become accretive in year 3 if the target grows faster than the acquirer. Show at least three years.
  • Not testing sensitivity. A table crossing the premium with the share of the price paid in stock shows at a glance where the line between accretion and dilution falls.

Our merger Excel model calculates pro forma EPS over several years, accretion or dilution according to the mix of stock, cash and debt, breakeven synergies and goodwill. It is a calculation tool: the result remains an estimate that depends on your assumptions, and is neither a certified valuation nor investment advice.